I am a postdoctoral fellow in the lab of Arnold Kriegstein at the University of California, San Francisco (UCSF). I focus on applying single-cell genomics techniques to study the development of specific cell types of the human brain, as well as to understand how these cell types are affected in various diseases, especially autism. Before starting my work at UCSF, I did my PhD at the University of Miami focusing on genomic analysis of autism. I did my B.S. and MS at Moscow State University in my native Russia, where I worked on animal models of epilepsy and Alzheimer’s disease.
Dmitry Velmeshev
Postdoctoral Scholar
University of California, San Francisco
From this contributor
Single-cell analysis suggests brain signaling problems in autism
Recent advances in technology allow researchers to measure RNA that is contained within the nucleus of a single brain cell.
Single-cell analysis suggests brain signaling problems in autism
By
Dmitry Velmeshev, The Conversation
22 May 2019 | 5 min read
Explore more from The Transmitter
European Research Council backtracks on stricter grant resubmission rules
The swift reversal came after more than 1,000 scientists signed an open letter protesting the rules last week.
European Research Council backtracks on stricter grant resubmission rules
The swift reversal came after more than 1,000 scientists signed an open letter protesting the rules last week.
By
Lauren Schenkman
1 May 2026 | 4 min read
What leeches reveal about movement
After encountering setbacks in her study of the neuromuscular system in vertebrates, Lidia Szczupak turned to leeches to explore how the nervous system coordinates movement.
What leeches reveal about movement
After encountering setbacks in her study of the neuromuscular system in vertebrates, Lidia Szczupak turned to leeches to explore how the nervous system coordinates movement.
By
Claudia López Lloreda
1 May 2026 | 5 min read
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
Novel assembloid illuminates serotonin changes linked to 22q11.2 deletion
The combination of a serotonin-producing organoid with an organoid based on the developing cerebral cortex offers a new way to investigate neuromodulation.
By
Sarah DeWeerdt
30 April 2026 | 0 min watch